Biotech Stock News: Prosensa Starts Rolling NDA Submission, Stock Reacts

Prosensa Holding N.V. (RNA) announced that it has initiated the process of rolling submission of a new drug application (NDA) to the FDA for its lead candidate, drisapersen, for the treatment of Duchenne muscular dystrophy (DMD). Drisapersen has Breakthrough Therapy Designation in the U.S. Moreover, the fast track status for drisapersen has made Prosensa eligible…

Read More

Stock in News: Google Inc (NASDAQ GOOG) Misses the Mark With Q3 Report but All Is Not Lost

Google Inc (NASDAQ GOOG) is a Mountain View, California based multinational corporation that specializes in Internet-related products and services. The Internet giant has a variety of services including search engines, online advertising, cloud computing, and software. Google announced its substandard third quarter report on Thursday, October 16th, making this the fourth consecutive quarter in which…

Read More
Home